Brazilian study maps HER2 in Women's cancers
NCT ID NCT07101081
First seen Mar 23, 2026 · Last updated May 10, 2026 · Updated 7 times
Summary
This study looks at how often a protein called HER2 is found at high levels in gynecological cancers like endometrial, ovarian, and cervical cancer. Researchers will test tumor samples from 350 adult patients in Brazil using standard lab methods. The goal is to better understand which patients might benefit from future HER2-targeted treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNAECOLOGICAL CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGSão Paulo, Brazil
Conditions
Explore the condition pages connected to this study.